- $2.09bn
- $1.98bn
- $225.21m
Brief: AxoGen Q4 Gross Margin 78.7%
AxoGen Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Axogen Announces Positive Topline Results From Repose
Brief: Axogen Reports Preliminary Unaudited Revenue For Fourth Quarter And Full-Year 2023
Brief: Axogen Announces Plan For Leadership Transition With CEO Karen Zaderej To Retire From Company By January 2025
Brief: Axogen- Board Increased Size Of Board From 9 Directors To 10 Directors
Brief: Axogen Appoints Kathy Weiler To Its Board Of Directors
Brief: Axogen Announces Transition Of Finance Team Leadership
U.S. RESEARCH ROUNDUP-Air Products and Chemicals, Assurant, Celanese
Brief: Axogen Maintains Full-Year 2023 Revenue Guidance Of $154 Million To $159 Million
Brief: AxoGen Q3 Revenue USD 41.3 Million Vs. IBES Estimate USD 40.5 Million
AxoGen Inc expected to post a loss of 6 cents a share - Earnings Preview
AxoGen Inc reports results for the quarter ended in June - Earnings Summary
Brief: AxoGen Q2 Revenue USD 38.2 Million Vs. IBES Estimate USD 39.1 Million
AxoGen Inc expected to post a loss of 13 cents a share - Earnings Preview
AxoGen Inc reports results for the quarter ended in March - Earnings Summary
Brief: Axogen, Inc Reports 2023 Q1 Financial Results
Brief: AxoGen Q1 revenue USD 36.7 million
AxoGen Inc expected to post a loss of 14 cents a share - Earnings Preview